Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin

Y. Kitagawa, H. Bujo, K. Takahashi, M. Shibasaki, K. Ishikawa, K. Yagui, N. Hashimoto, K. Noda, Tomonori Nakamura, S. Yano, Y. Saito

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Aim/hypothesis. Resistin, the expression of which is suppressed by thiazolidinedione treatment in adipocytes, is one of the key molecules for the tight link between adiposity and insulin resistance. Here, we show the in vivo effects of resistin on insulin sensitivity in mature mice using a cell implantation method. Methods. Resistin cDNA was transfected into 3T3-L1 pre-adipocytes, which were then implanted into subcutaneous areas of nude mice. Metabolic analyses were performed 4 or 6 weeks after implantation. Results. The mice implanted with 3T3-L1 cells overexpressing resistin (R-mice) showed significantly (p<0.05) increased plasma resistin levels. After a glucose load plasma insulin levels were significantly greater in R-mice than in mice implanted with mock-transfected cells (M-mice). The AUC of insulin after glucose loading was positively correlated with circulating resistin levels. Significantly decreased glucose responses after insulin injection were observed in R-mice, compared to M-mice. The insulin-induced phosphorylation level of IRS-1 was significantly lower in muscles of R-mice than M-mice. The expression of TNF-α mRNA in intra-peritoneal fat tissues was significantly greater in R-mice than in M-mice, but there was no difference between the two groups with regard to subcutaneous fat tissues. The concentration of TNF-α in plasma was positively correlated with resistin levels in R-mice. Conclusions/ interpretation. Resistin, when actually secreted from cells in mature mice, causes disturbed glucose metabolism, possibly based on decreased insulin sensitivity in muscle. The in vivo effects of resistin on insulin sensitivity might be in part mediated by increased TNF-α expression in visceral fat tissues.

Original languageEnglish
Pages (from-to)1847-1853
Number of pages7
JournalDiabetologia
Volume47
Issue number10
DOIs
Publication statusPublished - 2004 Oct
Externally publishedYes

Fingerprint

Resistin
Glucose Intolerance
Insulin Resistance
Insulin
Glucose
Adipocytes
3T3-L1 Cells
Muscles
Intra-Abdominal Fat
Subcutaneous Fat
Subcutaneous Tissue
Adiposity
Nude Mice
Area Under Curve

Keywords

  • Adipocytes
  • Implantation
  • Insulin sensitivity
  • Resistin
  • TNF-α

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin. / Kitagawa, Y.; Bujo, H.; Takahashi, K.; Shibasaki, M.; Ishikawa, K.; Yagui, K.; Hashimoto, N.; Noda, K.; Nakamura, Tomonori; Yano, S.; Saito, Y.

In: Diabetologia, Vol. 47, No. 10, 10.2004, p. 1847-1853.

Research output: Contribution to journalArticle

Kitagawa, Y, Bujo, H, Takahashi, K, Shibasaki, M, Ishikawa, K, Yagui, K, Hashimoto, N, Noda, K, Nakamura, T, Yano, S & Saito, Y 2004, 'Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin', Diabetologia, vol. 47, no. 10, pp. 1847-1853. https://doi.org/10.1007/s00125-004-1530-4
Kitagawa, Y. ; Bujo, H. ; Takahashi, K. ; Shibasaki, M. ; Ishikawa, K. ; Yagui, K. ; Hashimoto, N. ; Noda, K. ; Nakamura, Tomonori ; Yano, S. ; Saito, Y. / Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin. In: Diabetologia. 2004 ; Vol. 47, No. 10. pp. 1847-1853.
@article{ae6db98fda8a4c35ab657114a281b6d3,
title = "Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin",
abstract = "Aim/hypothesis. Resistin, the expression of which is suppressed by thiazolidinedione treatment in adipocytes, is one of the key molecules for the tight link between adiposity and insulin resistance. Here, we show the in vivo effects of resistin on insulin sensitivity in mature mice using a cell implantation method. Methods. Resistin cDNA was transfected into 3T3-L1 pre-adipocytes, which were then implanted into subcutaneous areas of nude mice. Metabolic analyses were performed 4 or 6 weeks after implantation. Results. The mice implanted with 3T3-L1 cells overexpressing resistin (R-mice) showed significantly (p<0.05) increased plasma resistin levels. After a glucose load plasma insulin levels were significantly greater in R-mice than in mice implanted with mock-transfected cells (M-mice). The AUC of insulin after glucose loading was positively correlated with circulating resistin levels. Significantly decreased glucose responses after insulin injection were observed in R-mice, compared to M-mice. The insulin-induced phosphorylation level of IRS-1 was significantly lower in muscles of R-mice than M-mice. The expression of TNF-α mRNA in intra-peritoneal fat tissues was significantly greater in R-mice than in M-mice, but there was no difference between the two groups with regard to subcutaneous fat tissues. The concentration of TNF-α in plasma was positively correlated with resistin levels in R-mice. Conclusions/ interpretation. Resistin, when actually secreted from cells in mature mice, causes disturbed glucose metabolism, possibly based on decreased insulin sensitivity in muscle. The in vivo effects of resistin on insulin sensitivity might be in part mediated by increased TNF-α expression in visceral fat tissues.",
keywords = "Adipocytes, Implantation, Insulin sensitivity, Resistin, TNF-α",
author = "Y. Kitagawa and H. Bujo and K. Takahashi and M. Shibasaki and K. Ishikawa and K. Yagui and N. Hashimoto and K. Noda and Tomonori Nakamura and S. Yano and Y. Saito",
year = "2004",
month = "10",
doi = "10.1007/s00125-004-1530-4",
language = "English",
volume = "47",
pages = "1847--1853",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin

AU - Kitagawa, Y.

AU - Bujo, H.

AU - Takahashi, K.

AU - Shibasaki, M.

AU - Ishikawa, K.

AU - Yagui, K.

AU - Hashimoto, N.

AU - Noda, K.

AU - Nakamura, Tomonori

AU - Yano, S.

AU - Saito, Y.

PY - 2004/10

Y1 - 2004/10

N2 - Aim/hypothesis. Resistin, the expression of which is suppressed by thiazolidinedione treatment in adipocytes, is one of the key molecules for the tight link between adiposity and insulin resistance. Here, we show the in vivo effects of resistin on insulin sensitivity in mature mice using a cell implantation method. Methods. Resistin cDNA was transfected into 3T3-L1 pre-adipocytes, which were then implanted into subcutaneous areas of nude mice. Metabolic analyses were performed 4 or 6 weeks after implantation. Results. The mice implanted with 3T3-L1 cells overexpressing resistin (R-mice) showed significantly (p<0.05) increased plasma resistin levels. After a glucose load plasma insulin levels were significantly greater in R-mice than in mice implanted with mock-transfected cells (M-mice). The AUC of insulin after glucose loading was positively correlated with circulating resistin levels. Significantly decreased glucose responses after insulin injection were observed in R-mice, compared to M-mice. The insulin-induced phosphorylation level of IRS-1 was significantly lower in muscles of R-mice than M-mice. The expression of TNF-α mRNA in intra-peritoneal fat tissues was significantly greater in R-mice than in M-mice, but there was no difference between the two groups with regard to subcutaneous fat tissues. The concentration of TNF-α in plasma was positively correlated with resistin levels in R-mice. Conclusions/ interpretation. Resistin, when actually secreted from cells in mature mice, causes disturbed glucose metabolism, possibly based on decreased insulin sensitivity in muscle. The in vivo effects of resistin on insulin sensitivity might be in part mediated by increased TNF-α expression in visceral fat tissues.

AB - Aim/hypothesis. Resistin, the expression of which is suppressed by thiazolidinedione treatment in adipocytes, is one of the key molecules for the tight link between adiposity and insulin resistance. Here, we show the in vivo effects of resistin on insulin sensitivity in mature mice using a cell implantation method. Methods. Resistin cDNA was transfected into 3T3-L1 pre-adipocytes, which were then implanted into subcutaneous areas of nude mice. Metabolic analyses were performed 4 or 6 weeks after implantation. Results. The mice implanted with 3T3-L1 cells overexpressing resistin (R-mice) showed significantly (p<0.05) increased plasma resistin levels. After a glucose load plasma insulin levels were significantly greater in R-mice than in mice implanted with mock-transfected cells (M-mice). The AUC of insulin after glucose loading was positively correlated with circulating resistin levels. Significantly decreased glucose responses after insulin injection were observed in R-mice, compared to M-mice. The insulin-induced phosphorylation level of IRS-1 was significantly lower in muscles of R-mice than M-mice. The expression of TNF-α mRNA in intra-peritoneal fat tissues was significantly greater in R-mice than in M-mice, but there was no difference between the two groups with regard to subcutaneous fat tissues. The concentration of TNF-α in plasma was positively correlated with resistin levels in R-mice. Conclusions/ interpretation. Resistin, when actually secreted from cells in mature mice, causes disturbed glucose metabolism, possibly based on decreased insulin sensitivity in muscle. The in vivo effects of resistin on insulin sensitivity might be in part mediated by increased TNF-α expression in visceral fat tissues.

KW - Adipocytes

KW - Implantation

KW - Insulin sensitivity

KW - Resistin

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=19944422710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944422710&partnerID=8YFLogxK

U2 - 10.1007/s00125-004-1530-4

DO - 10.1007/s00125-004-1530-4

M3 - Article

VL - 47

SP - 1847

EP - 1853

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 10

ER -